This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bone Metabolism Therapeutics Market To 2018 - Hyperparathyroidism Sector To Decline In The Absence Of New Product Launches And Increased Generic Erosion For Zemplar, Hectorol And Sensipar

Figure 26: Paget's Disease of Bone Therapeutics Market, Global, Treatment Usage Patterns (millions), 2002-2018 46

Figure 27: Paget's Disease of Bone Therapeutics Market, Treatment Flow Algorithm 48

Figure 28: Paget's Disease of Bone, Market Drivers and Barriers 49

Figure 29: Hyperparathyroidism Therapeutics Market, Global, Revenue Forecasts ($m), 2002-2018 50

Figure 30: Hyperparathyroidism Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2002-2018 52

Figure 31: Hyperparathyroidism Therapeutics Market, Global, Branded vs. Generic Share, 2010 and 2018 54

Figure 32: Hyperparathyroidism Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2018 55

Figure 33: Hyperparathyroidism Therapeutics Market, Global, Treatment Usage Patterns (millions), 2002-2018 56

Figure 34: Hyperparathyroidism Therapeutics Market, Treatment Flow Algorithm 58

Figure 35: Hyperparathyroidism, Market Drivers and Barriers 59

Figure 36: Bone Metastases Therapeutics Market, Global, Revenue Forecasts ($m), 2002-2018 61

Figure 37: Bone Metastases Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2002-2018 62

Figure 38: Bone Metastases Therapeutics Market, Global, Branded vs. Generic Share, 2010 and 2018 64

Figure 39: Bone Metastases Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2018 65

Figure 40: Bone Metastases Therapeutics Market, Global, Treatment Usage Patterns (thousands), 2002-2018 66

Figure 41: Bone Metastases Therapeutics Market, Treatment Flow Algorithm 68

Figure 42: Bone Metastases, Market Drivers and Barriers 69

Figure 43: Bone Metabolism Therapeutics Market, Global, R&D Pipeline by Indication (%), 2011 70

Figure 44: Bone Metabolism Therapeutics Market, Global, R&D Pipeline by Phase (%), 2011 71

Figure 45: Bone Metabolism Therapeutics Market, Global, SWOT - Amgen Inc. 88

Figure 46: Bone Metabolism Therapeutics Market, Global, SWOT - Abbott Laboratories 89

Figure 47: Bone Metabolism Therapeutics Market, Global, SWOT - Genzyme Corporation 90

Figure 48: Bone Metabolism Therapeutics Market, Global, SWOT - Merck & Co., Inc. 92

Figure 49: Bone Metabolism Therapeutics Market, Global, SWOT - Novartis AG 94

Figure 50: Bone Metabolism Therapeutics Market, Global, Deals by Indication, 2009-2011 95

9 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs